New to the community, but the resolution criteria as I understand them are not favorable to the question resolving positively. Mixed results in studies do not count: i.e. if only one group e.g. vaccinated people have a lower mortality but unvaccinated do not, the study does not count towards the 3 necessary studies. If one study reports significant reductions in hospitalizations, but only insignificant reductions in deaths because of a low sample size, it does not count either. To me it is also plausible, that earlier published studies (which is what t...

First (known to me) preprint, that gives an estimate for mortality, arriving at a significant reduction of deaths for Omicron: https://www.medrxiv.org/content/10.1101/2021.…

@(chrisjbillington) The Imperial Covid report 50 is addressing breakthrough infections, split up by vaccine type, boosters and time after last vaccine. My reading is that protection against hospitalization conditional on infection is mostly the same, the median estimates do not differ that much currently. Therefore I don't think that "without a doubt, Omicron is milder" in vaccinated. https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2021-12-22-COVID19-Report-50.pdf (Table 3, compare e.g. HR of "AZ:D2:14+" for Delta and Omicron) Als...

I would like to see a question regarding the outcome of a big trial currently being run by the NIH, investigating the efficacy of several potential treatments for Covid-19, in particular Fluvoxamine and Ivermectin. I have tried to create a question, but despite notifying several admins it has been pending for more than a month without feedback. Maybe a community member with more standing has more luck.

https://clinicaltrials.gov/ct2/show/NCT04885530